| Bioactivity | MDL3 is a novel inhibitor of PDE4B and PDE5A. MDL3 against liver injury and inflammation and inhibits the pathological remodeling of adipose tissue[1]. |
| Formula | C21H18F4N4O2 |
| Molar Mass | 434.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Dalton W Staller, ET AL. A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and metabolic diseases. Hepatology. 2024 Jul 1. |